InvestorsHub Logo
Followers 3
Posts 492
Boards Moderated 0
Alias Born 01/17/2016

Re: None

Friday, 09/27/2019 1:40:56 AM

Friday, September 27, 2019 1:40:56 AM

Post# of 424036
My Planning:

1) Alert 9/28 to see if anything from FDA (except the approval of the sNDA, I expect nothing else significant)
2) Expect the questionnaire come out by 11/14 (I expect the 11/14 AdCom will focus on the label expansion).
3) Won't sell a single share prior to 11/14, and make a new planning followed 11/14 AdCom.
4) If 11/14 AdCom results favorable Label to Vascepa, I will continue to hold all my shares till the end of Amarin (I expect a BO, but I welcome a solid GIA).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News